1. Home
  2. SCKT vs APRE Comparison

SCKT vs APRE Comparison

Compare SCKT & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Socket Mobile Inc.

SCKT

Socket Mobile Inc.

HOLD

Current Price

$0.90

Market Cap

7.1M

Sector

Technology

ML Signal

HOLD

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.89

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCKT
APRE
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
6.3M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
SCKT
APRE
Price
$0.90
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
20.6K
437.0K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.97
EPS
N/A
N/A
Revenue
$18,762,520.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.15
N/A
52 Week Low
$0.82
$0.55
52 Week High
$1.36
$2.79

Technical Indicators

Market Signals
Indicator
SCKT
APRE
Relative Strength Index (RSI) 33.25 57.42
Support Level $0.88 $0.55
Resistance Level $1.07 $1.02
Average True Range (ATR) 0.07 0.09
MACD -0.02 0.03
Stochastic Oscillator 1.56 87.25

Price Performance

Historical Comparison
SCKT
APRE

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Share on Social Networks: